Member log in

health and beauty product

Comvita annual earnings pip 2013, meeting guidance; shares fall

Brett Hewlett, Comvita CEO

Ebos meets guidance as first half profit more than triples, Aussies take over

Mark Waller

Comvita posts 1H loss on margin squeeze, competition in Australia, UK

Neil Craig

Trilogy forecasts smaller first-half loss, softens FY guidance

Trilogy 12-month price history (NZX.com)

Trilogy International forecasts a small first-half loss while tipping a second-half pickup which would help it to almost meet guidance for the full year.

Nasdaq-listed Derma Sciences takes 7.3 percent stake in Comvita in discounted placement

Comvita chairman Neil Craig

Blis K12 probiotic to take on bad dog breath

The Dunedin-based NZX-listed bioscience company says the recent success of a first-phase trial on dogs has encouraged an expanded trial.